Skip to main content
Top

Endocrine Pathology

Issue 2/2016

Content (12 Articles)

Role of Histological Criteria and Immunohistochemical Markers in Predicting Risk of Malignancy in Parathyroid Neoplasms

Niraj Kumari, Nandita Chaudhary, Roma Pradhan, Amit Agarwal, Narendra Krishnani

Establishment and Characterization of a Human Neuroendocrine Tumor Xenograft

Zhaoying Yang, Le Zhang, Stefano Serra, Calvin Law, Alice Wei, Tracy L. Stockley, Shereen Ezzat, Sylvia L. Asa

Clinical Impact of the Current WHO Classification of Pituitary Adenomas

W. Saeger, J. Honegger, M. Theodoropoulou, U. J. Knappe, C. Schöfl, S. Petersenn, R. Buslei

Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification

W. Saeger, S. Petersenn, C. Schöfl, U. J. Knappe, M. Theodoropoulou, R. Buslei, J. Honegger

Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification

David S. Priemer, Rodolfo Montironi, Lisha Wang, Sean R. Williamson, Antonio Lopez-Beltran, Liang Cheng

A Case of Cushing’s Syndrome with Multiple Adrenocortical Adenomas Composed of Compact Cells and Clear Cells

Masahiro Asakawa, Takanobu Yoshimoto, Mitsutane Ota, Mitsuyuki Numasawa, Yuriko Sasahara, Takato Takeuchi, Yujiro Nakano, Norihiko Oohara, Masanori Murakami, Ryotaro Bouchi, Isao Minami, Kyoichiro Tsuchiya, Koshi Hashimoto, Hajime Izumiyama, Naoko Kawamura, Kazunori Kihara, Mariko Negi, Takumi Akashi, Yoshinobu Eishi, Hironobu Sasano, Yoshihiro Ogawa

A Novel Mutation in a Patient with Hyperparathyroidism–Jaw Tumour Syndrome

Virginia Bellido, Ihintza Larrañaga, Maite Guimón, Rafael Martinez-Conde, Asier Eguia, Gustavo Perez de Nanclares, Luis Castaño, Sonia Gaztambide

Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements

Akeesha A. Shah, N. Paul Ohori, Linwah Yip, Christopher Coyne, Cristina R. Antonescu, Raja R. Seethala

Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF V600E Harboring Pediatric Papillary Thyroid Carcinomas

Semen Onder, Sule Ozturk Sari, Gulcin Yegen, Ismail Cem Sormaz, Ismail Yilmaz, Sukran Poyrazoglu, Yasemin Sanlı, Yasemin Giles Senyurek, Yersu Kapran, Ozgur Mete

The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors

Sule Ozturk Sari, Orhun Cig Taskin, Gokcen Gundogdu, Gulcin Yegen, Semen Onder, Metin Keskin, Sezer Saglam, Yasemin Ozluk, Mine Gulluoglu, Ozgur Mete

Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles

Marco Manzoni, Francesca Bono, Andrew Smith, Giovanni Cavenaghi, Werner Garavello, Fabio Pagni

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine